ACADIAN ASSET MANAGEMENT LLC - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 86 filers reported holding ENZO BIOCHEM INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q4 2021$26,000
-60.6%
8,279
-71.9%
0.00%
Q2 2020$66,000
-80.9%
29,454
-78.4%
0.00%
-100.0%
Q1 2020$345,000
-11.8%
136,325
-8.4%
0.00%0.0%
Q4 2019$391,000
-38.0%
148,783
-15.0%
0.00%
-33.3%
Q3 2019$631,000
+1.0%
175,109
-5.5%
0.00%0.0%
Q2 2019$625,000
-28.7%
185,271
-42.3%
0.00%
-25.0%
Q1 2019$876,000
-21.3%
321,062
-19.8%
0.00%
-33.3%
Q4 2018$1,113,000
-41.2%
400,200
-12.8%
0.01%
-25.0%
Q3 2018$1,894,000
-24.1%
459,050
-4.5%
0.01%
-27.3%
Q2 2018$2,494,000
-16.9%
480,916
-12.2%
0.01%
-15.4%
Q1 2018$3,002,000
-59.8%
547,809
-40.2%
0.01%
-59.4%
Q4 2017$7,465,000
-28.8%
915,921
-8.5%
0.03%
-30.4%
Q3 2017$10,480,000
-13.9%
1,000,726
-9.2%
0.05%
-16.4%
Q2 2017$12,174,000
+22.1%
1,102,548
-7.4%
0.06%
+19.6%
Q1 2017$9,967,000
+19.2%
1,190,805
-1.2%
0.05%
+12.2%
Q4 2016$8,361,000
+31.5%
1,204,933
-3.5%
0.04%
+32.3%
Q3 2016$6,356,000
-18.4%
1,249,042
-4.3%
0.03%
-22.5%
Q2 2016$7,792,000
+27.8%
1,305,377
-2.5%
0.04%
+29.0%
Q1 2016$6,095,000
+141.9%
1,338,714
+139.1%
0.03%
+138.5%
Q4 2015$2,520,000
+1591.3%
559,955
+1092.8%
0.01%
+1200.0%
Q3 2015$149,000
-44.4%
46,946
-46.9%
0.00%0.0%
Q2 2015$268,000
-65.2%
88,445
-66.2%
0.00%
-75.0%
Q1 2015$770,000
-30.2%
261,324
+5.2%
0.00%
-20.0%
Q4 2014$1,103,000
-13.6%
248,340
+0.1%
0.01%
-16.7%
Q3 2014$1,277,000
+117.2%
247,969
+121.2%
0.01%
+100.0%
Q2 2014$588,000112,1070.00%
Other shareholders
ENZO BIOCHEM INC shareholders Q1 2019
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,436,771$7,822,00010.43%
VIEX Capital Advisors, LLC 1,736,087$5,573,0008.96%
HARBERT FUND ADVISORS, INC. 5,175,913$16,615,0004.19%
AMH Equity Ltd 596,742$1,916,0002.66%
Potomac Capital Management, Inc. 208,000$668,0000.59%
Agate Pass Investment Management, LLC 24,292$78,0000.05%
RBF Capital, LLC 250,359$804,0000.05%
KEMPNER CAPITAL MANAGEMENT INC. 25,475$82,0000.05%
Corsair Capital Management 58,657$188,0000.04%
BOOTHBAY FUND MANAGEMENT, LLC 319,500$1,026,0000.02%
View complete list of ENZO BIOCHEM INC shareholders